TCF4

For the Transcription factor 7-like 2 gene, also known as TCF4, see TCF7L2.
Transcription factor 4
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols TCF4 ; E2-2; ITF-2; ITF2; PTHS; SEF-2; SEF2; SEF2-1; SEF2-1A; SEF2-1B; SEF2-1D; TCF-4; bHLHb19
External IDs OMIM: 602272 MGI: 98506 HomoloGene: 2407 GeneCards: TCF4 Gene
Orthologs
Species Human Mouse
Entrez 6925 21413
Ensembl ENSG00000196628 ENSMUSG00000053477
UniProt P15884 Q60722
RefSeq (mRNA) NM_001083962 NM_001083967
RefSeq (protein) NP_001077431 NP_001077436
Location (UCSC) Chr 18:
55.22 – 55.66 Mb
Chr 18:
69.34 – 69.69 Mb
PubMed search

Transcription factor 4 (TCF-4) also known as immunoglobulin transcription factor 2 (ITF-2) is a protein that in humans is encoded by the TCF4 gene located on chromosome 18q21.1.[1]

Function

TCF4 proteins act as transcription factors which will bind to the immunoglobulin enhancer mu-E5/kappa-E2 motif. TCF4 activates transcription by binding to the E-box (5’-CANNTG-3’) found usually on SSTR2-INR, or somatostatin receptor 2 initiator element. TCF4 is primarily involved in neurological development of the fetus during pregnancy by initiating neural differentiation by binding to DNA. It is found in the central nervous system, somites, and gonadal ridge during early development. Later in development it will be found in the thyroid, thymus, and kidneys while in adulthood TCF4 it is found in lymphocytes, muscles, and gastrointestinal system.[2][3]

Clinical significance

Mutations in TCF4 cause Pitt-Hopkins Syndrome (PTHS). These mutations cause TCF4 proteins to not bind to DNA properly and control the differentiation of the nervous system. In most cases that have been studied, the mutations were de novo, meaning it was a new mutation not found in other family members of the patient. Common symptoms of Pitt-Hopkins Syndrome include a wide mouth, gastrointestinal problems, developmental delay of fine motor skills, speech and breathing problems, epilepsy, and other brain defects.[4][5]

References

  1. Henthorn P, McCarrick-Walmsley R, Kadesch T (Feb 1990). "Sequence of the cDNA encoding ITF-2, a positive-acting transcription factor". Nucleic Acids Research 18 (3): 678. doi:10.1093/nar/18.3.678. PMC 333500. PMID 2308860.
  2. de Pontual L, Mathieu Y, Golzio C, Rio M, Malan V, Boddaert N, et al. (Apr 2009). "Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome". Human Mutation 30 (4): 669–76. doi:10.1002/humu.20935. PMID 19235238.
  3. Pscherer A, Dörflinger U, Kirfel J, Gawlas K, Rüschoff J, Buettner R, Schüle R (Dec 1996). "The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene". The EMBO Journal 15 (23): 6680–90. PMID 8978694.
  4. Amiel J, Rio M, de Pontual L, Redon R, Malan V, Boddaert N, et al. (May 2007). "Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction". American Journal of Human Genetics 80 (5): 988–93. doi:10.1086/515582. PMID 17436254.
  5. Zweier C, Peippo MM, Hoyer J, Sousa S, Bottani A, Clayton-Smith J, et al. (May 2007). "Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome)". American Journal of Human Genetics 80 (5): 994–1001. doi:10.1086/515583. PMC 1852727. PMID 17436255.

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article is issued from Wikipedia - version of the Tuesday, January 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.